Caricamento...
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
BACKGROUND: One of the major challenges in diagnosing dementia with Lewy bodies (DLB) is the common co-morbid presence of amyloid pathology. To understand the putative role of altered amyloid-β (Aβ) metabolism in dementia with DLB, we analyzed levels of different cerebrospinal fluid (CSF) Aβ peptide...
Salvato in:
| Pubblicato in: | Alzheimers Res Ther |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788069/ https://ncbi.nlm.nih.gov/pubmed/31601267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0537-5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|